FDA Adverse Event Injury Summary report: N

ACUITY

MDR report key: 1861010 · Received October 7, 2010

Report

Report Number
2124215-2010-15341
Event Type
Injury
Date Received
October 7, 2010
Date of Event
July 27, 2010
Report Date
August 19, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
OJX
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, VISUAL INSPECTION OF THE LEAD NOTED DRIED BLOOD IN THE LEAD LUMEN. THE LEAD DID NOT ALLOW INSERTION OF A STYLET DUE TO THE DRIED BLOOD. THE LEAD PASSED CONDUCTOR RESISTANCE, HIGH POTENTIAL, AND INSULATION PRESSURE TESTING, CONFIRMING BOTH THE CONDUCTOR AND INSULATION WERE UNCOMPROMISED. ANALYSIS WAS UNABLE TO CONFIRM OR REFUTE THE CAUSE OF THE DISLODGEMENT.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS LEFT VENTRICULAR (LV) LEAD DISLODGED ONE DAY POST-IMPLANT. IN A REVISION PROCEDURE, THE LEAD EXHIBITED LOSS OF CAPTURE AND DIAPHRAGMATIC STIMULATION. THE LEAD WAS EXPLANTED AND SUCCESSFULLY REPLACED BY A NEW LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

--

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACUITY IMPLANTABLE LEAD OJX CPI - DEL CARIBE 4554

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening| R